![Nicholas Virca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Virca
Chief Executive Officer at
Hedgepath LLC
Net worth: 776 749 $ as of 31/08/2026
Profile
Nicholas Jon Virca is currently the President, Chief Executive Officer & Director at Hedgepath LLC since 2012.
Previously, he held the position of President & Chief Executive Officer at Mast Therapeutics, Inc. from 1997 to 2004.
He also served as the President & Chief Executive Officer at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Additionally, he worked as a Director at Panoptix Events from 2007 to 2017 and as a Director at Diametrix Detectors, Inc. from 1991 to 1997.
Furthermore, he held the role of Vice President-Global Biotechnology at Pall Corp.
and Cytiva US LLC from 2005 to 2008.
Lastly, he served as the Chief Operating Officer at LamdaGen Corp.
from 2008 to 2012.
Mr. Virca obtained his undergraduate degree from Youngstown State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/08/2026 | 8,727,519 ( 5.02% ) | 776 749 $ | 31/08/2026 |
Nicholas Virca active positions
| Companies | Position | Start |
|---|---|---|
Hedgepath LLC | Chief Executive Officer | 01/04/2012 |
Former positions of Nicholas Virca
| Companies | Position | End |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Chief Executive Officer | 13/12/2022 |
Panoptix Events
 Panoptix Events Miscellaneous Commercial ServicesCommercial Services Operates as a event planning agency | Director/Board Member | 01/01/2017 |
LamdaGen Corp.
 LamdaGen Corp. Miscellaneous Commercial ServicesCommercial Services Develops proprietary biosensors and instruments | Chief Operating Officer | 01/04/2012 |
| PALL CORPORATION | Corporate Officer/Principal | 01/01/2008 |
Cytiva US LLC
 Cytiva US LLC BiotechnologyHealth Technology Develops and manufactures of biotherapeutics, cell and gene therapies | Corporate Officer/Principal | 01/01/2008 |
Training of Nicholas Virca
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Pall Corp.
 Pall Corp. Industrial MachineryProducer Manufacturing Designs, manufactures and markets filtration & separation equipment | Producer Manufacturing |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Hedgepath LLC | |
Youngstown State University
 Youngstown State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Develops and manufactures of biotherapeutics, cell and gene therapies | Health Technology |
LamdaGen Corp.
LamdaGen Corp. Miscellaneous Commercial ServicesCommercial Services Develops proprietary biosensors and instruments | Commercial Services |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Panoptix Events
Panoptix Events Miscellaneous Commercial ServicesCommercial Services Operates as a event planning agency | Commercial Services |
Diametrix Detectors, Inc. |
- Stock Market
- Insiders
- Nicholas Virca
